INFLAMMATION 1
P79: THE INFLUENCE OF CELL SEPARATION TECHNIQUES ON PERIPHERAL BLOOD CELL GENE EXPRESSION SIGNATURES
PA Lyons, Cambridge Institute for Medical Research

P80: MANIPULATION OF THE PD1/PDL1 NEGATIVE T CELL COSTIMULATORY PATHWAY IN THE TREATMENT OF ESTABLISHED EXPERIMENTAL AUTOIMMUNE GLOMERULONEPHRITIS
J Reynolds, Imperial College London

P81: A KEY ROLE FOR SP1 AND SP3 IN THE CONSTITUTIVE TRANSCRIPTION OF THE HUMAN HYALURONAN SYNTHASE 2 GENE IN THE KIDNEY
T Bowen, Cardiff University

P82: ADRENOMEDULLIN POTENTIATES TNF-? INDUCED IMMUNE AND INFLAMMATORY RESPONSES IN PROXIMAL TUBULAR EPITHELIAL CELLS (HKC-8)
A Pearson, St Helier Hospital, Carshalton

P83: PMNS AS APCS IN TRANSPLANTATION: BRIDGING INNATE AND ADAPTIVE IMMUNITY
LR Ambrose, Imperial College London

P84: THE ROLE OF DECAY ACCELERATING FACTOR IN THE PATHOGENESIS OF ATYPICAL HAEMOLYTIC URAEMIC SYNDROME
D Kavanagh, Washington University School of Medicine, USA

P85: DEFICIENCY OF C4 FROM DONOR OR RECIPIENT MOUSE FAILS TO PREVENT RENAL ALLOGRAFT REJECTION
T Lin, King's College and St Thomas' Hospitals, London

P86: MOLECULAR MECHANISMS FOR NF-?B INHIBITION BY A20, AN ANTI-INFLAMMATORY PROTEIN
K Enesa, Imperial College London

P87: BLOCKADE OF OX40-LIGAND AFTER INITIAL TRIGGERING OF THE TH2-RESPONSE INHIBITS MERCURIC CHLORIDE-INDUCED AUTOIMMUNITY
IAM MacPhee, St. George's University of London

P88: LOCAL EXTRAVASCULAR POOL OF C3 IS A DETERMINANT OF POST-ISCHAEMIC ACUTE RENAL FAILURE
CA Farrar, King's College London

P89: THE ROLE OF THE ALTERNATIVE PATHWAY IN ACCELERATED SERUM NEPHROTOXIC NEPHRITIS IN C57BL/6 MICE
D Turnberg, Hammersmith Hospital, London

P90: PROGRESSIVE INJURY IN UNILATERAL URETERIC OSTRUCTION IS INDEPENDENT OF TLR2 AND TLR4
P Chowdhury, Guy's Hospital, London

P91: SIROLIMUS AMELIORATES THE IMBALANCE OF INTRACELLULAR CHOLESTEROL HOMEOSTASIS IN HUMAN VASCULAR SMOOTH MUSCLE CELLS MEDIATED BY INFLAMMATORY CYTOKINE
K Ma, Royal Free and UC Medical School, London

TUBULAR BIOLOGY 2  
P92: HIGH GLUCOSE-INDUCED PROXIMAL TUBULAR EPITHELIAL CELL DEATH IS MEDIATED BY INCREASED OXIDATION OF POLYAMINES
DA Allen, William Harvey Research Institute, London

P93: IDENTIFICATION AND CHARACTERIZATION OF A NOVEL HUMAN GENE ATP6V0E2, ENCODING A NEW ISOFORM OF THE V-ATPASE E SUBUNIT
KG Blake-Palmer, University of Cambridge

P94: AVOIDING AMMONIUM CHLORIDE CHALLENGE: UTILITY OF THE FUROSEMIDE/FLUDROCORTISONE URINE ACIDIFICATION TEST.
A Viljoen, Addenbrookes Hospital, Cambridge

P95: ERK, P38 AND SMAD SIGNALLING PATHWAYS DIFFERENTIALLY REGULATE TGF-?1 AUTO-INDUCTION IN PROXIMAL TUBULAR EPITHELIAL CELLS
D J Fraser, Cardiff University

P96: TGF?1-INDUCED FIBRONECTIN PRODUCTION IN PROXIMAL TUBULAR EPITHELIAL CELLS IS MEDIATED BY ALK5 RECEPTOR, REGULATED BY P38 MAP KINASE BUT IS SMAD INDEPENDENT
I Niculescu-Duvaz, St Helier Hospital, Carshalton

P97: CHARACTERIZATION OF THE HUMAN KIDNEY-SPECIFIC H+-ATPASE 'G' SUBUNIT REVEALS ITS PRESENCE IN THE INNER EAR AND IDENTIFIES A NOVEL INTERACTION WITH THE 'A' SUBUNIT
E E Norgett, University of Cambridge

P98: SCREENING TEST FOR DISTAL RENAL TUBULAR ACIDOSIS; AN ALTERNATIVE TO AMMONIUM CHLORIDE
SB Walsh, Royal Free and UC Medical School, London

P99: IMMUNOFLUORESCENT LOCALISATION OF ATP-ACTIVATED P2 RECEPTORS IN THE RAT COLLECTING DUCT AND EFFECT OF ALTERING DIETARY SODIUM INTAKE
SS Wildman, Royal Free and UC Medical School, London

P100: PURINOCEPTOR REGULATION OF AQP2-MEDIATED WATER TRANSPORT IN THE COLLECTING DUCT: A ROLE FOR APICALLY EXPRESSED P2 RECEPTORS
SS Wildman, Royal Free and UC Medical School, London

P101: RECONSTRUCTION OF GLOMERULI FIXED UNDER PHYSIOLOGICAL PRESSURES SHOW HIGHLY RESTRICTIVE ROUTES FOR FLUID MOVEMENT TO THE PROXIMAL CONVOLUTED TUBULE (PCT)
CR Neal, University of Bristol

P102: ALTERATIONS IN NOVEL GENES IN HUMAN METANEPHRIC MESENCHYMAL CELLS FOLLOWING LEUKAEMIA INHIBITORY FACTOR (LIF) TREATMENT
K L Price, University College London

ACUTE RENAL FAILURE     
P103: CONTINUOUS VERSUS INTERMITTENT RENAL REPLACEMENT THERAPY FOR ACUTE RENAL FAILURE: A SYSTEMATIC REVIEW OF RCTS
KS Rabindranath, University of Aberdeen

P104: ACUTE RENAL FAILURE: EPIDEMIOLOGY AND PREDICTION OF OUTCOMES
TZ Ali, University of Aberdeen

P105: A 5 CENTRE AUDIT OF ACUTE RENAL FAILURE - LESSONS FOR INTER-UNIT COMPARISON AND INTRA-UNIT SERVICE PLANNING
CH Jones, York Hospital

P106: ACUTE RENAL FAILURE IN ICU - EVALUATION OF THE RIFLE CLASSIFICATION
ME Ostermann, St George's Hospital, London

P107: ADVANCED AGE AND PRE-EXISTING CORONARY HEART DISEASE ARE POOR PROGNOSTIC INDICATORS IN ACUTE RENAL FAILURE (ARF) TREATED WITH RENAL REPLACEMENT THERAPY
R J Westacott, Leicester General Hospital

P108: INTRAVITAL MICROSCOPY INDICATES SYSTEMIC MICRO-VASCULAR DYSFUNCTION IN MURINE RENAL ISCHAEMIA/ REPERFUSION (I/R) INJURY.
JE Kieswich, William Harvey Research Institute, London

P109: INCIDENCE OF CONTRAST-INDUCED NEPHROPATHY IN PATIENTS UNDERGOING NON-CORONARY ANGIOGRAPHY
MR Clatworthy, University of Cambridge

HYPERTENSION (CLINICAL)    
P110: INTEGRATING PRIMARY AND SECONDARY CARE FOR BLOOD PRESSURE CONTROL IN DIABETIC NEPHROPATHS: A NURSE LED ALGORITHM AS A MODEL FOR CARE OF CHRONIC DISEASE
SG Riley, University Hospital of Wales

P111: ANGIOTENSIN CONVERTING ENZYME (ACE) GENE POLYMORPHISM IS ASSOCIATED WITH HYPERTENSION IN PATIENTS ON HAEMODIALYSIS
M Varagunam, William Harvey Research Institute, London

P112: CLINIC VERSUS AMBULATORY BLOOD PRESSURE DIFFERENCES IN PATIENTS WITH CKD: A MARKER OF ASSOCIATED VASCULAR DISEASE?
M.W. Taal, Derby City General Hospital

P113: BLOOD PRESSURE VARIABILITY IN HAEMODIALYSIS PATIENTS IN ENGLAND AND WALES
JM Harper, Royal Liverpool University Hospital

P114: TARGETED INTERVENTIONS TO IMPROVE BLOOD PRESSURE CONTROL IN PRIMARY CARE
J Balazs, Modernisation Initiaitve, London

TRANSPLANT (CLINICAL) 2   
P115: OUT COME OF PANCREAS TRANSPLANTATION IN A DEVELOPING PROGRAMME. RESOURCE INTENSIVE BUT REWARDING
A Tavakoli, Manchester Institute of Nephrology and Transplantation

P116: ANAEMIA AFTER RENAL TRANSPLANTATION: ANALYSIS OF A SINGLE CENTRE POPULATION
I El Madhoun, St James's University Hospital, Leeds

P117: CARDIORESPIRATORY FITNESS IS RELATED TO PHYSICAL INACTIVITY, METABOLIC SYNDROME AND ATHEROSCLEROTIC BURDEN IN INSULIN-RESISTANT RENAL TRANSPLANT RECIPIENTS
K Armstrong, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia

P118: DOES ANGIOTENSIN BLOCKADE INFLUENCE GRAFT OUTCOME IN RENAL TRANSPLANTATION RECIPIENTS WITH IGA NEPHROPATHY?
AE Courtney, Belfast City Hospital

P119: COMPARISON OF TRANSPLANT LISTING STRATEGY IN TWO RENAL DIALYSIS CENTERS WITHIN A REGIONAL TRANSPLANT ALLIANCE
RF Jeffrey, St Luke's Hospital, Bradford

P120: THE ROLE OF STRESS MYOVIEW SCANNING IN PRE-TRANSPLANT ASSESSMENT
H Wootton, York Hospital

P121: INFLUENZA AND PNEUMOCOCCAL VACCINATIONS ARE SIMILIARLY EFFECTIVE IN TRANSPLANT RECIPIENTS MAINTAINED ON CALCINEURIN INHIBITOR OR SIROLIMUS BASED IMMUNOSUPPRESSION.
LC Willcocks, Addenbrooke's Hospital, Cambridge

P122: COMPREHENSIVE ANTIBODY SCREENING FOR HYPERCOAGULABLE STATES IDENTIFIES AT RISK RENAL PATIENTS
S Goel, Hammersmith Hospital, London

P123: CONVERSION FROM CYCLOSPORIN (CYA) TO MYCOPHENOLATE-BASED IMMUNOSUPPRESSION PROLONGS KIDNEY GRAFT SURVIVAL IN PATIENTS WITH CHRONIC ALLOGRAFT NEPHROPATHY (CAN)
A Boswell, Nottingham City Hospital

P124: CAN AN INCREASE IN OVERALL MYCOPHENOLIC ACID (MPA) EXPOSURE BE ACHIEVED IN PATIENTS ON REDUCED DOSE MYCOPHENOLATE MOFETIL (MMF) DUE TO GASTROINTESTINAL SIDE EFFECTS BY CONVERSION TO ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS)
A Boswell, Nottingham City Hospital

HAEMODIALYSIS 2      
P125: URGENT DIALYSIS INITIATION IN PATIENTS KNOWN TO RENAL SERVICES
J Buck, Leicester General Hospital

P126: TGI FRIDAY!
DJ Border, St James University Hospital, Leeds

P127: PATIENTS ROUTINELY EXERCISING ON HAEMODIALYSIS - IS IT FEASIBLE?
V A Pursey, York Hospital

P128: INTERDIALYTIC WEIGHT GAIN, SALT AND WATER: EDUCATION IS NEEDED FOR DIALYSIS STAFF AS WELL AS PATIENTS
H Scott, Leeds General Infirmary

P129: EVALUATION OF A LOW-COST, HIGH-FLUX DIALYSER
K Baharvand, Dewsbury District Hospital

P130: CIGARETTE SMOKING AMONGST HAEMODIALYSIS PATIENTS
A Sharma, Royal Liverpool University Hospital

P131: STAFF KNOWLEDGE AND ATTITUDE REGARDING INFECTION CONTROL AND BLOOD BORNE VIRUSES
K.L. Wood, Sheffield Kidney Institute

P132: SAFETY AND EFFICACY OF LOW MOLECULAR WEIGHT HEPARIN ON HAEMODIALYSIS
K Bramham, St Helier Hospital, Carshalton

P133: NATIONAL SURVEY OF HEPARIN INDUCED THROMBOCYTOPENIA IN THE HAEMODIALYSIS POPULATION OF THE UNITED KINGDOM
CA Hutchison, Queen Elizabeth Hospital, Birmingham

P134: SURVEY OF PREVALENT HOSPITAL HAEMODIALYSIS PATIENTS TO IDENTIFY THOSE SUITABLE FOR HOME HAEMODIALYSIS: AN AUDIT OF NICE HOME HAEMODIALYSIS GUIDANCE
H El-Shazly, Leicester General Hospital

P135: PREDICTORS OF MORTALITY IN CHRONIC HAEMODIALYSIS PATIENTS DIALYSING THROUGH DIALYSIS CATHETERS (DC)
K R Wallace, York Hospital

P136: EFFECTIVE MANAGEMENT OF PAIN IN A PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD)
L Ridley,York Hospital

BONE DISEASE 1    
P137: RE-INTRODUCING ALUMINIUM HYDROXIDE AS A PHOSPHATE BINDER - SAFETY OF TREATMENT AND EFFECTS ON POPULATION BONE MINERAL BALANCE
L Ridley, York Hospital

P138: VASCULAR CALCIFICATION IS ASSOCIATED WITH IMPAIRED MICROCIRCULATORY FUNCTION IN CHRONIC HAEMODIALYSIS PATIENTS
MK Sigrist, Derby City General Hospital

P139: IMPROVE YOUR RESULTS - USE YOUR DIETITIAN!
Y Bradburn, Birmingham Heartlands Hospital

P140: OSTEOTROPIC FACTORS AND SKELETAL FUNCTION IN CHRONIC HAEMODIALYSIS PATIENTS
WS Priestman, Derby City Hospital

P141: RISK OF FRACTURE AMONG DIALYSIS AND RENAL TRANSPLANT RECIPIENTS
SD Roe, Nottingham City Hospital

P142: BONE CHEMISTRY MANAGEMENT: FACTORS INFLUENCING PHOSPHATE BINDER PRESCRIBING
E Bailey, Royal Preston Hospital

P143: AFFECT OF IL-6 GENOTYPE ON INTACT PTH LEVELS IN STABLE HAEMODIALYSIS PATIENTS
T Pile, Royal London Hospital

P144: AUDIT OF COMPLIANCE WITH ERA/EDTA 2002 STANDARDS FOR BONE PROTECTION IN A RENAL TRANSPLANT POPULATION
A Richards, Washington University School of Medicine, USA

P145: CINACALCET IN SEVERE HYERPARATHYROIDISM
F C Symes, Derby City General Hospital

MODERNISATION   
P146: PATIENT AND PUBLIC INVOLVEMENT
A Waller, St Lukes Hospital, Bradford

P147: THE ADMINISTRATION OF INTRAVENOUS (IV) IRON SUCROSE (VENOFER(r)) IN THE HOME.
B Dring, Nottingham City Hospital

P148: A MODEL FOR PLANNING FUTURE HAEMODIALYSIS FACILITIES IN WALES - FIELDS OF DREAMS
K Donovan, Welsh Assembly Government

P149: ACCESS TO HAEMODIALYSIS (HD) FACILITIES IN WALES
K Donovan, Welsh Assembly Government

P150: STAFF SURVEY - ATTITUDES SURROUNDING DIALYSIS SUPPORT NURSES COMMENCING DIALYSIS USING A CENTRA VENOUS CATHETER
S R de Waal, Nottingham City Hospital

P151: THE CHALLENGES OF THE "RENAL OUTLIER"
KE Taylor, Nottingham City Hospital

P152: DEMAND FOR ONLINE INFORMATION ON KIDNEY DISEASE
T F Statham OBE, National Kidney Federation, Worksop

P153: NON MEDICAL PRESCRIBING IN RENAL SERVICES
W Brown, Watford General Hospital, London

P154: DEVELOPING THE NOVEL ROLE OF RENAL GENETICS NURSE SPECIALIST - A NEW WAY OF WORKING
DA Spencer, Addenbrookes Hospital, Cambridge

P155: ASSESSMENT OF PROGRESS IN RENAL NSF PART 1; PATIENT SURVEY DEVELOPED BY CRITERIA FOR SUCCCESS GROUP
RM Higgins, University Hospitals Coventry and Warwickshire NHS Trust

P156: PREPARATION FOR RENAL REPLACEMENT THERAPY IN CRISIS: COMPARISON TO THE NSF MARKERS OF GOOD PRACTICE
RJ Middleton, Hope Hospital, Salford

P157: THE RECONFIGURATION OF NURSING SERVICES TO MAKE PRE-EMPTIVE TRANSPLANTATION A KEY PRIORITY.
AE Northwood, Hope Hospital, Salford

P158: WRITING CLINIC LETTERS TO PATIENTS: A STEP TOWARDS PATIENT CENTRED CARE
S Smith, Birmingham Heartlands Hospital

PERITONEAL DIALYSIS     
P159: ASSISTED APD USING HEALTH-CARE ASSISTANTS: RESULTS OF A PILOT STUDY
K Pryde, Hammersmith Hopital, London

P160: AN AUDIT INTO FACTORS DETERMINING THE UPTAKE OF PERITONEAL DIALYSIS (PD) IN THE UNIVERSITY HOSPITALS BIRMINGHAM (UHB) RENAL UNIT
D Cartlidge, University of Birmingham

P161: PLASMA AND DIALYSATE ICODEXTRIN METABOLITE PROFILES
RB Asghar, University Hospital of North Staffordshire

P162: MEETING THE NEEDS OF THE DIABETIC PATIENT ON PERITONEAL DIALYSIS
C Fox, Hope Hospital, Salford

P163: AN EXCEPTIONAL CASE. 21 YEARS OF CONTINUOUS PERITONEAL DIALYSIS INCLUDING 12.5 YEARS OF ICODEXTRIN.
SB Jenkins, Sheffield Kidney Institute

P164: CT SCANNING IN THE DETECTION OF EARLY PERITONEAL SCLEROSIS
H E HURST, Manchester Royal Infirmary

P165: ENCAPSULATING PERITONEAL SCLEROSIS FOLLOWING RENAL TRANSPLANTATION
DG de Freitas, Manchester Royal Infirmary

P166: DO PATIENTS RECEIVING AUTOMATED PERITONEAL DIALYSIS NEED A POTASSIUM RESTRICTION?
F Przygrodzka, Nottingham City Hospital

P167: MULTI-CENTRE, PROSPECTIVE AUDIT OF SWITCHING FROM PERITONEAL DIALYSIS TO HAEMODIALYSIS
S Davies, North Staffordshire Royal Infirmary

P168: FDG PET SCANS IN LONG TERM PERITONEAL DIALYSIS PATIENTS MAY DETECT AN INFLAMMATORY PHASE OF ENCAPSULATING PERITONEAL SCLEROSIS: EVIDENCE FROM DIALYSATE MCP-1 LEVELS
S Ahmad, Imperial College London